Centene employees rate the overall compensation and benefits . Candidates should demonstrate an interest in learning IAM and Security themes. Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. She oversees corporate strategy, internal audit, compliance and risk management, and digital strategy. Salaries posted anonymously by Centene employees. CENTENE CORP annual reports of executive compensation and pay are most commonly found in the Def 14a documents. Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings. Effective March 1, 2021, the following appointments have been made: Mr. Layton, Ms. London, and Ms. Bagley will continue to report toMichael Neidorff, Chairman, President and Chief Executive Officer ofCentene. Here are further demographic highlights of the leadership team: The Centene executive team is 39% female and 61% male. Without limiting the foregoing, forward-looking statements often use words such as "believe," "anticipate," "plan," "expect," "estimate," "intend," "seek," "target," "goal," "may," "will," "would," "could," "should," "can," "continue" and other similar words or expressions (and the negative thereof). Our local approach allows us to help members access high-quality, culturally sensitive Copyrights Executive Mosaic - All Rights Reserved. The charts on this page feature a breakdown of the total annual pay for the top executives at CENTENE CORP as reported in their proxy statements. Brent Layton, senior adviser to the CEO. Drew Asher, CFO. About usGovernment Contracting FAQGuest Contributions2022 Events, Your Direct Source for Government Contracting News. London . Kenneth Burdick, Retired Executive Vice President of Products and Markets of Centene Corporation; Former Chief Executive Officer of WellCare Health Plans, Inc. Christopher Coughlin, Former Executive Vice President and Chief Financial Officer of Tyco International, Ltd. Wayne DeVeydt, Executive Chairman of Surgery Partners, Inc.; Former Executive Vice President and Chief Financial Officer of Anthem, Inc. Orlando Ayala, Retired Chairman and Corporate Vice President of Emerging Businesses for Microsoft Corporation, Jessica L. Blume, Retired Vice Chairman of Deloitte LLP, Frederick H. Eppinger, President and Chief Executive Officer of Stewart Title Guaranty Company, Richard A. Gephardt, Chief Executive Officer and President of Gephardt Group, LLC; Former Majority Leader of the U.S. House of Representatives, Lori J. Robinson, Retired United States Air Force General, William Trubeck, Retired Chief Financial Officer, Director, and Executive Vice President of YRC Worldwide; Retired Executive Vice President and Chief Financial Officer of H&R Block, A Leading Provider of Quality and Affordable Healthcare, NAVSEA Uses Digital Tools to Demo Bridge Validation for Constellation-class Frigate Design, DARPA to Sponsor Proposers Day for Speed and Runway-Independent X-Plane Project, Johns Hopkins APL Publishes Findings From Double Asteroid Redirection Test, CISA, FBI Release Joint Cybersecurity Advisory on Royal Ransomware, DOE Issues Application Guidance for 2nd Civil Nuclear Credit Program Award Cycle, Suggestions Sought on Possible Advanced Technological Uses of ISS National Laboratory, HII, Ocean Aero Collaborate on Unmanned Maritime Platforms, Autonomy Software, CISA Requests Info on Insight Branchs Cybersecurity Risk Management Requirement, Microsoft-Mitre Partnership Seeks to Address Potential AI/ML Vulnerabilities With New Plug-in, Navy Receives 4th Expeditionary Sea Base Vesel From General Dynamics Unit, Authentication Company Aware to Demo Biometric Tech at Future Digital Finance Conference; Craig Herman Quoted, Boeing-Built Apache Helicopter Hits 5M Flight Hours. London continues to put her stamp on Centenes leadership, elevating Fasola to President from his current position as executive vice president of healthcare enterprises. James Dallas - Chairman of the Centene Board of Directors. Cookie Policy. removing social barriers to health, and prioritizing responsible She previously served as chief medical officer for Covered California, the state's health insurance marketplace. We strive to offer services that other Medicaid and Medicare managed care companies do not. Here is the list of the latest directors and independent directors of the company. Brent Layton oversees the management team in creating health plans, products, business marketing, and business development. The Company takes a local approach with local brands and local teams to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. DeVeydt is also a former executive vice president and CFO of Anthem, Inc. Orlando Ayala is a retired chairman and corporate vice president of emerging businesses for Microsoft Corporation. General Manager | Jeremy Huelsing. Ken Fasola, president. removing social barriers to health, and prioritizing responsible William Trubeck is now a member of the boards of Centene Corp and the Monmouth University Alumni Association. Other executives include Drew Asher, Chief Financial Officer; Jim Murray, Chief Operating Officer and 17 others. Learn about the executive team and board of directors at Centene Corp (CNC:XNYS) and review their bios and compensation over the latest fiscal years. 26 on the 2022 FORTUNE 500 list of largest U.S. corporations by revenue. Opinions expressed by Forbes Contributors are their own. Centene is an equal opportunity employer that is committed to diversity, and values the ways in which we are different. The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Jim Murray, COO. Centene offers affordable and high-quality products to nearly 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by theHealth Insurance Marketplace, the TRICARE program, and individuals in correctional facilities. He has more than 30 years of finance experience and formerly worked at different companies in the healthcare industry like Aetna and Coventry Health Care. Frederick H. Eppinger is president and CEO of Stewart Title Guaranty Company. Centene shuffled its senior management ranks Wednesday, elevating Ken Fasola to become president of the health insurer, reporting to chief executive officer Sarah London. Mr. Asher has served as Centene's CFO since 2021. Elizabeth Brinn started Centene Corporation in 1984 as a non-profit Medicaid plan. Sarah London is the Chief Executive Officer of Centene Corporation, a diversified healthcare enterprise providing a portfolio of government-sponsored healthcare programs focusing on under-insured and uninsured individuals to more than 26 million Americans. These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments and other factors we believe appropriate. Steady, organic growth and a series of strategic acquisitions have transformed us from a regional player to a national powerhouse. Before Centene, Brinn worked as a bookkeeper at a hospital. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to: the impact of COVID-19 on global markets, economic conditions, the healthcare industry and our results of operations and the response by governments and other third parties; the risk that regulatory or other approvals required for the Magellan Acquisition may be delayed or not obtained or are obtained subject to conditions that are not anticipated that could require the exertion of management's time and our resources or otherwise have an adverse effect on us; the risk that Magellan Health's stockholders do not approve the definitive merger agreement; the possibility that certain conditions to the consummation of the Magellan Acquisition will not be satisfied or completed on a timely basis and accordingly the Magellan Acquisition may not be consummated on a timely basis or at all; uncertainty as to the expected financial performance of the combined company following completion of the Magellan Acquisition; the possibility that the expected synergies and value creation from the Magellan Acquisition or the WellCare Acquisition will not be realized, or will not be realized within the applicable expected time periods; the exertion of management's time and our resources, and other expenses incurred and business changes required, in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for the Magellan Acquisition; the risk that unexpected costs will be incurred in connection with the completion and/or integration of the Magellan Acquisition or that the integration of Magellan Health will be more difficult or time consuming than expected; the risk that potential litigation in connection with the Magellan Acquisition may affect the timing or occurrence of the Magellan Acquisition or result in significant costs of defense, indemnification and liability; a downgrade of the credit rating of our indebtedness, which could give rise to an obligation to redeem existing indebtedness; the possibility that competing offers will be made to acquire Magellan Health; the inability to retain key personnel; disruption from the announcement, pendency and/or completion and/or integration of the Magellan Acquisition or the integration of the WellCare Acquisition, or similar risks from other acquisitions we may announce or complete from time to time, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators, making it more difficult to maintain business and operational relationships; our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates due to the impact of COVID-19; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies, and advances in medicine; increased healthcare costs; changes in economic, political or market conditions; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act (ACA) and the Health Care and Education Affordability Reconciliation Act, collectively referred to as the ACA and any regulations enacted thereunder that may result from changing political conditions, the new administration or judicial actions, including the ultimate outcome in "Texas v. United States of America" regarding the constitutionality of the ACA; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses; our ability to adequately price products; tax matters; disasters or major epidemics; changes in expected contract start dates; provider, state, federal, foreign and other contract changes and timing of regulatory approval of contracts; the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE or other customers); the difficulty of predicting the timing or outcome of pending or future legal and regulatory proceedings or government investigations; challenges to our contract awards; cyber-attacks or other privacy or data security incidents; the possibility that the expected synergies and value creation from acquired businesses, including businesses we may acquire in the future, will not be realized, or will not be realized within the expected time period; the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for acquisitions; disruption caused by significant completed and pending acquisitions making it more difficult to maintain business and operational relationships; the risk that unexpected costs will be incurred in connection with the completion and/or integration of acquisition transactions; changes in expected closing dates, estimated purchase price and accretion for acquisitions; the risk that acquired businesses will not be integrated successfully; restrictions and limitations in connection with our indebtedness; our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth; availability of debt and equity financing, on terms that are favorable to us; inflation; foreign currency fluctuations; and risks and uncertainties discussed in the reports that Centene has filed with the Securities and Exchange Commission. Learn about the key responsibilities of Centene Corporation leaders, founders, executives, and their achievements throughout the years. Centene Corporation; Facility Overview; Tenants; CENTENE CORP annual reports of executive compensation and pay are most commonly found in the Def 14a documents. Sarah London is the Chief Executive Officer of Centene Corporation, a diversified healthcare enterprise providing a portfolio of government-sponsored healthcare programs focusing on under-insured and uninsured individuals to more than 26 million Americans. Prior to Optum Ventures, Ms. London served as Chief Product Officer for Optum Analytics, the business unit responsible for driving strategy and commercialization of Optum's integrated data and analytics solutions into the provider, payer and life sciences markets. Centenefocuses on long-term growth and the development of its people, systems and capabilities so that it can better serve its members, providers, local communities, and government partners. This 2022, there are changes in Centene Corp leaders and directors as part of its current board renewal and collaboration agreement with Politan Capital Management. Meet Our Team. He is also in charge of the companys value-based purchasing, making sure that the organization provides quality health care. Ms. London received an M.B.A. with High Honors from the University of Chicago Booth School of Business and a B.A. Sarah M. London - Chief Executive Officer. Centene said in a statement released Wednesday. Echo Street Capital Management LLC purchased a new stake in Centene Co. (NYSE:CNC - Get Rating) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC).The institutional investor purchased 17,338 shares of the company's stock, valued at approximately $1,349,000. Ms. Bagley works closely with leadership to set the companys people agenda and goals. Forward-Looking Statements All statements, other than statements of current or historical fact, contained in this press release are forward-looking statements. 20th Annual Spine, Orthopedic & Pain Management-Driven ASC Conference, 8th Annual Health IT + Digital Health + RCM Conference, 29th Annual Meeting - The Business & Operations of ASCs, Digital Health + Telehealth Virtual Event, Why hospitals could be facing millions of newly uninsured patients this year, Large health system vs. payer profits in 2022, Bright Health has 'substantial doubt' about company's future, posts $669M Q4 loss, Medicare Advantage gross margins per enrollee are double other insurance markets, report finds, Humana, Aledade ink 10-year agreement for value-based senior primary care, North Carolina lawmakers reach Medicaid expansion deal, Humana lays out another $1.25B debt offering, Insurers accused of offering 'lavish vacations' to brokers for selling Medigap plans, MyChart message fees live on unstable ground, The 20% Medicare cut coming for hospitals, 'The house always wins': Insurers' record profits clash with hospitals' hardship, Meet America's largest employer of physicians: UnitedHealth Group, HHS to maintain COVID-19 public health emergency past January, HHS renews COVID-19 PHE for 11th time here's why, Humana laying off over 1,100 associates, shuttering all SeniorBridge locations, 50 things to know about Medicare Advantage, 'It's like a shakedown': Payers, providers ditch the hushed voices in their fights, CMS proposes rule to improve the prior authorization process, Apple reportedly launching health insurance in 2024, Insurers that face the largest potential Medicare Advantage payment clawbacks, Bright Health faces possible New York Stock Exchange delisting, Dr. Sachin Jain: It's time to end 'magical thinking' in healthcare, UnitedHealth to integrate behavioral, home health into growing number of value-based care models, Anthem Blue Cross axes $40K bill after patient appeals on TikTok, Federal judge rules against HHS again over surprise-billing arbitration rule, HHS extends COVID-19 public health emergency to April, UnitedHealth Group posts $4.9B profit in fourth quarter, Medicare Advantage plans deny the most inpatient level-of-care claims: report, California health system could split with UnitedHealth, Anthem, Cigna, Vanderbilt Health dropping Humana, Wellcare Medicare Advantage plans, 'Already a three-headed dragon': Medical groups rebuke judge's approval of UnitedHealth, Change merger, The elephant in the room: 'Insurtechs' aren't working, CVS reports $2.3B Q4 profit, will buy Oak Street Health, Why North Carolina unanimously chose Aetna over BCBS, Payers are steering their members to Mark Cuban's pharmacy. Ms. London was named CEO in March. Theodore Samuels is a retired president of Capital Guardian Trust Company. All proxy statements are public filings made available to the general public by the SEC. ST. LOUIS, March 1, 2021 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today announced four executive leadership appointments to support the company's continued growth . Mar 01, 2021, 07:00 ET. ", "I am honored and humbled to have been selected as the next CEO of Centene and to work alongside extraordinary colleagues to provide quality healthcare to over 26 million Americans," said Ms. London. "Additionally, we are excited to welcome two new leaders to our senior management team. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. afficher des publicits et des contenus personnaliss en fonction de vos profils de centres dintrt; mesurer lefficacit des publicits et contenus personnaliss; et. Orlando Ayala - Former Corporate Vice . (AP Photo/Jeff Roberson, File). Mr. Trubeck has a wide range of experience in public company governance and organizations with over $1 billion in revenues. See the full leadership team at Craft. Our commitment to quality improvement has earned us numerous health plan accreditations and program awards. Biography. London, who became Centenes chief executive officer less than nine months ago, succeeded long-time top executive Michael Neidorff, who retired. Mr. Andrew L. Asher has been the Executive Vice President and Chief Financial Officer of the company since 2021. Her previous roles in the company include vice chair and senior vice president of technology innovation and modernization.